Published in Epigenetics on November 01, 2010
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
The functional role of long non-coding RNA in human carcinomas. Mol Cancer (2011) 6.37
Transcriptional regulation and its misregulation in disease. Cell (2013) 2.92
Concern The functional role of long non-coding RNAs and epigenetics. Biol Proced Online (2014) 1.73
Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer. Int J Biol Sci (2013) 1.62
Regulation of chromatin structure by long noncoding RNAs: focus on natural antisense transcripts. Trends Genet (2012) 1.46
Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol Cell Ther (2015) 1.32
Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res (2011) 1.31
Long noncoding RNA involvement in cancer. BMB Rep (2012) 1.28
Dysregulation of RNA polymerase I transcription during disease. Biochim Biophys Acta (2012) 1.16
Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders. Front Genet (2012) 1.13
ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci (2013) 1.07
Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci U S A (2013) 1.04
Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog (2013) 1.01
Regulators of gene expression as biomarkers for prostate cancer. Am J Cancer Res (2012) 0.98
Expression and significance of histone H3K27 demethylases in renal cell carcinoma. BMC Cancer (2012) 0.97
Long non-coding RNAs and their implications in cancer epigenetics. Biosci Rep (2013) 0.95
EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection. Front Genet (2013) 0.91
Emerging epigenetic mechanisms of long non-coding RNAs. Neuroscience (2013) 0.91
Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog (2013) 0.90
Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes. PLoS Biol (2013) 0.90
Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers. Int J Clin Exp Pathol (2014) 0.90
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation. EMBO J (2013) 0.89
Copy number variation in patients with cervical artery dissection. Eur J Hum Genet (2012) 0.87
Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value. Biomed Res Int (2015) 0.84
Long non-coding RNAs in haematological malignancies. Int J Mol Sci (2013) 0.83
Polycomb repressive complex PRC2 regulates Xenopus retina development downstream of Wnt/β-catenin signaling. Development (2013) 0.83
Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation. Dev Biol (2015) 0.83
Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology. Epigenetics (2013) 0.83
The genome landscape of the african green monkey kidney-derived vero cell line. DNA Res (2014) 0.81
Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget (2016) 0.81
Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases. Neurotherapeutics (2014) 0.80
Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation. PLoS One (2013) 0.80
Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug Response. Int J Mol Sci (2015) 0.79
Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease. Curr Top Microbiol Immunol (2016) 0.78
Chromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke. Transl Stroke Res (2011) 0.78
Aberrant Endometrial DNA Methylome and Associated Gene Expression in Women with Endometriosis. Biol Reprod (2016) 0.78
Inactivation of p15(INK4b) in chronic arsenic poisoning cases. Toxicol Rep (2014) 0.77
Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases. Aging Dis (2016) 0.77
Regulation of CDKN2B expression by interaction of Arnt with Miz-1--a basis for functional integration between the HIF and Myc gene regulatory pathways. Mol Cancer (2014) 0.77
Role of Ink4a/Arf locus in beta cell mass expansion under physiological and pathological conditions. J Diabetes Res (2014) 0.77
Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle (2013) 0.77
Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals. Cell Res (2015) 0.77
Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases. Int J Mol Sci (2016) 0.77
Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions. BMC Med Genet (2012) 0.76
Islet biology, the CDKN2A/B locus and type 2 diabetes risk. Diabetologia (2016) 0.76
Association of CDKN2B-AS1 rs1333049 with Brain Diseases: A Case-control Study and a Meta-analysis. Clin Psychopharmacol Neurosci (2017) 0.75
Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the DPYD enigma. Transl Neurosci (2015) 0.75
SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development. Oncogene (2016) 0.75
CDKN2B methylation is associated with carotid artery calcification in ischemic stroke patients. J Transl Med (2016) 0.75
DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis. Sci Rep (2015) 0.75
Noncoding RNAs in neurodegeneration. Nat Rev Neurosci (2017) 0.75
Roles of microRNAs and Long Noncoding RNAs in the Progression of Diabetic Retinopathy. Biosci Rep (2017) 0.75
Decreased expression of the long non-coding RNA MLLT4 antisense RNA 1 is a potential biomarker and an indicator of a poor prognosis for gastric cancer. Oncol Lett (2017) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science (2002) 24.31
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A (2009) 20.66
A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 20.37
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67
Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell (2002) 13.05
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell (2002) 12.28
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47
Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
Role of histone H2A ubiquitination in Polycomb silencing. Nature (2004) 9.48
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
The regulation of INK4/ARF in cancer and aging. Cell (2006) 8.75
Ink4a/Arf expression is a biomarker of aging. J Clin Invest (2004) 8.30
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature (2008) 7.64
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell (1995) 7.34
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77
Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev (1994) 6.10
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (1994) 6.06
Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol Cell Biol (2006) 5.99
The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. Mol Cell (1998) 5.79
Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol (1999) 5.78
Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene (1997) 5.64
Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer (2009) 4.40
Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol Cell (2010) 4.36
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature (2001) 4.14
Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev (2005) 3.89
The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat Struct Mol Biol (2008) 3.80
Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature (2010) 3.77
A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities. Genes Dev (2006) 3.49
A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell (2010) 3.27
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature (2007) 3.26
The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev (2009) 3.04
Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol (2006) 2.99
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev (2009) 2.98
Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol (2003) 2.96
INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One (2009) 2.77
Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci U S A (2003) 2.67
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet (2010) 2.39
Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol (2007) 2.27
Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest (1999) 2.27
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature (2007) 2.20
SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol (2008) 2.14
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res (1997) 2.12
Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J (2007) 1.99
Transcription factor YY1 functions as a PcG protein in vivo. EMBO J (2003) 1.95
Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J (2006) 1.88
Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst (2008) 1.78
P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J Biol Chem (2003) 1.67
Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc Natl Acad Sci U S A (2008) 1.55
Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc Natl Acad Sci U S A (2009) 1.54
MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem (2004) 1.48
A common variant of the p16(INK4a) genetic region is associated with physical function in older people. Mech Ageing Dev (2007) 1.39
Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res (2009) 1.28
Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras. Proc Natl Acad Sci U S A (2010) 1.28
Gene silencing by DNA methylation in haematological malignancies. Br J Haematol (2007) 1.20
Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann Hum Genet (2008) 1.09
Pc-G/trx-G and the SWI/SNF connection: developmental gene regulation through chromatin remodeling. Genesis (2000) 0.95
An INKlination for epigenetic control of senescence. Nat Struct Mol Biol (2008) 0.91
Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94
Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69
A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev (2009) 2.98
Myc confers androgen-independent prostate cancer cell growth. J Clin Invest (2003) 1.65
Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep (2010) 1.38
Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev (2012) 1.34
Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell (2011) 1.33
Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression. Cell Stem Cell (2012) 1.33
Senescence: a new weapon for cancer therapy. Trends Cell Biol (2012) 1.25
A role for CXCR2 in senescence, but what about in cancer? Cancer Res (2009) 1.19
Control of senescence by CXCR2 and its ligands. Cell Cycle (2008) 1.17
Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L. Oncogene (2002) 1.15
DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. Aging Cell (2013) 0.90
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation. EMBO J (2013) 0.89
A genetic screen identifies topoisomerase 1 as a regulator of senescence. Cancer Res (2009) 0.86
Unbiased characterization of the senescence-associated secretome using SILAC-based quantitative proteomics. Methods Mol Biol (2013) 0.83
Design of a soil cutting resistance sensor for application in site-specific tillage. Sensors (Basel) (2013) 0.79
Design of a new sensor for determination of the effects of tractor field usage in southern Spain: soil sinkage and alterations in the cone index and dry bulk density. Sensors (Basel) (2012) 0.78
Structure-activity relationship in the interaction of substituted perinaphthenones with Mycosphaerella fijiensis. J Agric Food Chem (2009) 0.77
The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell (2015) 0.77
Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle (2013) 0.77
New apocarotenoids and β-carotene cleavage in Blakeslea trispora. Org Biomol Chem (2011) 0.77
Erratum: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol (2015) 0.75
Primary cilia and senescence: a sensitive issue. Cell Cycle (2014) 0.75
[Evaluation E-test method to determine the antimicrobial activity of ceftaroline against methicillin-resistant strains of Staphylococcus aureus]. Rev Esp Quimioter (2014) 0.75
Postoperative costs associated with outcomes after cardiac surgery with extracorporeal circulation: role of antithrombin levels. J Cardiothorac Vasc Anesth (2012) 0.75